Literature DB >> 27829526

Sex-specific incidence rates and risk factors of premature cardiovascular disease. A long term follow up of the Tehran Lipid and Glucose Study.

Ali Eslami1, Amirhossein Mozaffary2, Arash Derakhshan2, Fereidoun Azizi3, Davood Khalili2, Farzad Hadaegh4.   

Abstract

OBJECTIVES: To investigate the risk factors for premature cardiovascular disease (CVD) and to quantify their population attributable fractions (PAFs) among an Iranian population during a median follow-up of 12years.
METHODS: A total of 2235 men and 3703 women, aged ≥30years, free of CVD at baseline were entered into the study. Premature CVD was defined as having a history of CVD events before the age of 55 and 65 for men and women, respectively. Multivariate Cox proportional hazard regression models were used to determine the risk factors associated with premature CVD events.
RESULTS: During the study, incident rates of premature CVD were 4.8 and 3.9 per 1000 person years for men and women, respectively. Low HDL-C [Hazard ratio: 1.74, 95% confidence interval: 1.11-2.74], hypercholesterolemia [3.01: 2.02-4.49], current smoker [1.68: 1.12-2.51], family history of premature CVD [2.04: 1.36-3.07], hypertension [1.65: 0.97-2.81, P=0.06] and type 2 diabetes(T2D) [1.98: 1.16-3.40] were significant predictors among men; the corresponding PAFs were 32.7, 29.4, 19.4, 14.9, 8.7 and 7.9%, respectively. Among women, T2D [3.02: 2.08-4.39], hypercholesterolemia [1.65: 1.19-2.29], being overweight [1.79: 1.01-3.17], hypertension [1.54: 1.01-2.34], family history of premature CVD [1.65: 1.19-2.29], high physical activity [0.67: 0.46-0.96] and prediabetes [1.48: 1.00-2.18] were significant predictors; the corresponding PAFs were 25.4, 22.5, 18.5, 16.8, 11.4, -10.3 and 9.1%, respectively.
CONCLUSIONS: Considering the high burden imposed on health system by cardio-metabolic risk factors, dietary, behavioral and pharmacological interventions are need to be initiated early to prevent premature CVD, taking into account the sex-related differences between risk factors.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Incidence; Population attributable fraction; Premature cardiovascular disease; Risk factor

Mesh:

Substances:

Year:  2016        PMID: 27829526     DOI: 10.1016/j.ijcard.2016.10.037

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  17 in total

1.  Sex Difference in the Association between Lipid Profile and Incident Cardiovascular Disease among Young Adults.

Authors:  Tatsuya Kamon; Hidehiro Kaneko; Hidetaka Itoh; Akira Okada; Satoshi Matsuoka; Hiroyuki Kiriyama; Katsuhito Fujiu; Kojiro Morita; Nobuaki Michihata; Taisuke Jo; Norifumi Takeda; Hiroyuki Morita; Sunao Nakamura; Koichi Node; Hideo Yasunaga; Issei Komuro
Journal:  J Atheroscler Thromb       Date:  2022-01-07       Impact factor: 4.394

2.  Population attributable fraction estimates of cardiovascular diseases in different levels of plasma total cholesterol in a large-scale cross-sectional study: a focus on prevention strategies and treatment coverage.

Authors:  Sina Azadnajafabad; Maryam Karimian; Shahin Roshani; Negar Rezaei; Esmaeil Mohammadi; Sahar Saeedi Moghaddam; Erfan Ghasemi; Fatemeh Sadeghi Morasa; Nazila Rezaei; Arya Aminorroaya; Ali Ghanbari; Maryam Nasserinejad; Fateme Gorgani; Bagher Larijani; Farshad Farzadfar
Journal:  J Diabetes Metab Disord       Date:  2020-11-10

3.  A new look at risk patterns related to coronary heart disease incidence using survival tree analysis: 12 Years Longitudinal Study.

Authors:  Azra Ramezankhani; Farideh Bagherzadeh-Khiabani; Davood Khalili; Fereidoun Azizi; Farzad Hadaegh
Journal:  Sci Rep       Date:  2017-06-12       Impact factor: 4.379

4.  Different Weight Histories and Risk of Incident Coronary Heart Disease and Stroke: Tehran Lipid and Glucose Study.

Authors:  Maryam Kabootari; Samaneh Asgari; Mohammad Ali Mansournia; Davood Khalili; Majid Valizadeh; Fereidoun Azizi; Farzad Hadaegh
Journal:  J Am Heart Assoc       Date:  2018-02-10       Impact factor: 5.501

5.  Anthropometric measures and the risk of coronary artery disease.

Authors:  Aidin Baghbani-Oskouei; Mehrzad Gholampourdehaki
Journal:  Caspian J Intern Med       Date:  2020

Review 6.  Tobacco Smoking: Findings from 20 Years of the Tehran Lipid and Glucose Study.

Authors:  Donna Parizadeh; Amir Abbas Momenan; Atieh Amouzegar; Fereidoun Azizi; Farzad Hadaegh
Journal:  Int J Endocrinol Metab       Date:  2018-10-31

Review 7.  Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS).

Authors:  Hengameh Abdi; Atieh Amouzegar; Maryam Tohidi; Fereidoun Azizi; Farzad Hadaegh
Journal:  Int J Endocrinol Metab       Date:  2018-10-20

8.  Cardiovascular mortality in a Western Asian country: results from the Iran Cohort Consortium.

Authors:  Noushin Fahimfar; Davood Khalili; Sadaf Ghajarieh Sepanlou; Reza Malekzadeh; Fereidoun Azizi; Mohammad Ali Mansournia; Hamidreza Roohafza; Mohammad Hassan Emamian; Farzad Hadaegh; Hossein Poustchi; Marjan Mansourian; Hassan Hashemi; Maryam Sharafkhah; Akram Pourshams; Farshad Farzadfar; Ewout W Steyerberg; Akbar Fotouhi
Journal:  BMJ Open       Date:  2018-07-05       Impact factor: 2.692

9.  Incidence and associated risk factors for premature death in the Tehran Lipid and Glucose Study cohort, Iran.

Authors:  Ali Eslami; Seyed Sina Naghibi Irvani; Azra Ramezankhani; Nazanin Fekri; Keyvan Asadi; Fereidoun Azizi; Farzad Hadaegh
Journal:  BMC Public Health       Date:  2019-06-10       Impact factor: 3.295

10.  Long term prognostic implication of newly detected abnormal glucose tolerance among patients with stable cardiovascular disease: a population-based cohort study.

Authors:  Maryam Kabootari; Samaneh Asgari; Seyedeh Maryam Ghavam; Hengameh Abdi; Fereidoun Azizi; Farzad Hadaegh
Journal:  J Transl Med       Date:  2021-06-30       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.